PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,361,500 | -87.8% | 150,000 | -77.9% | 0.01% | -86.7% |
Q2 2023 | $27,584,305 | -69.2% | 678,247 | -63.3% | 0.06% | -70.1% |
Q1 2023 | $89,468,680 | +11781.6% | 1,847,000 | +12213.3% | 0.20% | +9950.0% |
Q3 2022 | $753,000 | -68.7% | 15,000 | -75.0% | 0.00% | -66.7% |
Q2 2022 | $2,404,000 | -50.4% | 60,000 | -53.8% | 0.01% | -33.3% |
Q1 2022 | $4,850,000 | +1077.2% | 130,000 | +983.3% | 0.01% | +800.0% |
Q4 2018 | $412,000 | -89.9% | 12,000 | -86.2% | 0.00% | -88.9% |
Q3 2018 | $4,089,000 | +66.4% | 87,000 | -75.1% | 0.01% | +28.6% |
Q2 2016 | $2,457,000 | +52.6% | 350,000 | +40.0% | 0.01% | +75.0% |
Q1 2016 | $1,610,000 | -75.1% | 250,000 | +100.0% | 0.00% | -75.0% |
Q4 2014 | $6,471,000 | -51.0% | 125,000 | -58.3% | 0.02% | -51.5% |
Q3 2014 | $13,203,000 | +18.4% | 300,000 | -29.7% | 0.03% | +13.8% |
Q2 2014 | $11,153,000 | +14.0% | 426,666 | -26.0% | 0.03% | +11.5% |
Q4 2013 | $9,786,000 | +185.0% | 576,666 | +260.4% | 0.03% | +160.0% |
Q3 2013 | $3,434,000 | – | 160,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |